Adherence to Prophylaxis in Adolescents and Young Adults with Severe Haemophilia: A Quantitative Study with Patients

Sandra B van Os1, Nick A Troop1, Keith R Sullivan1

  • 1Psychology and Sport Sciences Department, School of Life and Medical Sciences, University of Hertfordshire, Hatfield, United Kingdom.

Plos One
|January 20, 2017
PubMed

Insights

Adherence to haemophilia prophylaxis is generally good among young people in the UK. Psychosocial factors like perceived need for treatment and social support significantly influence adherence, guiding future interventions.

Area of Science:

  • Hematology
  • Psychology
  • Public Health

Background:

  • Haemophilia is a severe inherited bleeding disorder requiring regular factor concentrate prophylaxis.
  • Adherence to weekly prophylactic treatment is crucial for managing bleeds and improving quality of life in young people.
  • Existing adherence data for young haemophilia patients is limited and often based on estimations.

Purpose of the Study:

  • To evaluate self-reported adherence to haemophilia prophylaxis in young individuals.
  • To identify psychosocial predictors associated with treatment adherence.
  • To determine the correlation between non-adherence and clinical outcomes like bleeds and hospital visits.

Main Methods:

  • A questionnaire-based study involving 91 young people with haemophilia across 13 UK centers.
  • Assessment of adherence using VERITAS-Pro, alongside psychosocial factors (illness perceptions, self-efficacy, social support, etc.).
  • Collection of clinical data on bleeds and hospital visits from medical records.

Main Results:

  • Only 18% of participants with complete data exhibited non-adherence.
  • Psychosocial predictors varied for intentional (skipping) versus unintentional (forgetting) non-adherence.
  • Higher adherence correlated with greater perceived need for prophylaxis, positive outcome expectations, strong social support, and emotional impact of haemophilia.

Conclusions:

  • Self-reported adherence to haemophilia prophylaxis is generally good in young people.
  • Assessing illness beliefs, treatment perceptions, social support, and outcome expectations can identify at-risk individuals.
  • Interventions should focus on enhancing social support, addressing concerns, reinforcing prophylaxis necessity, and improving outcome expectations.
Abstract

Related Concept Videos

Venous Thrombosis III: Interprofessional Care01:29

Venous Thrombosis III: Interprofessional Care

Venous thrombosis requires effective prevention and treatment strategies to improve patient outcomes and reduce potential complications.Prevention StrategiesHealthcare providers must prioritize preventing venous thromboembolism (VTE) for all adult patients upon admission. Interventions depend on bleeding and thrombosis risk, medical history, current medications, diagnoses, planned procedures, and patient preferences. Patients on bed rest should change positions every two hours and, if not...
432
Anticoagulant Drugs: Low-Molecular-Weight Heparins01:30

Anticoagulant Drugs: Low-Molecular-Weight Heparins

Hemostasis is a crucial process that prevents excessive blood loss from damaged blood vessels. It involves various mechanisms such as vasoconstriction, platelet adhesion and activation, and fibrin formation. The importance of each mechanism depends on the type of vessel injury. In contrast, thrombosis is the abnormal formation of a blood clot within the blood vessels, leading to potential complications if the clot obstructs blood flow. Thrombosis can be caused by increased coagulability of the...
2.2K
Pharmacokinetics in Pediatric Patients: Drug Excretion01:26

Pharmacokinetics in Pediatric Patients: Drug Excretion

In pediatric medicine, understanding the renal function and drug elimination nuances is crucial for administering safe and effective treatments. Newborns, in particular, display markedly slower renal functions than adults, profoundly affecting how drugs are cleared from their bodies. This slower drug clearance requires clinicians to extend the dosing intervals for many medications to prevent drug accumulation and toxicity while ensuring therapeutic efficacy.One key area where these adjustments...
343
Venous Thrombosis IV: Nursing Management01:30

Venous Thrombosis IV: Nursing Management

Nursing management begins with a thorough assessment of the patient's health history. Key factors include trauma to veins, peripherally inserted central catheters, varicose veins, recent pregnancy or childbirth, surgery, bacteremia, prolonged bed rest, atrial fibrillation, COPD, heart failure, cancer, coagulation disorders, myocardial infarction, spinal cord injury, stroke, prolonged travel, recent bone fractures, and dehydration. Review medication intake, particularly oral contraceptives,...
341
Disorders of Hemostasis01:24

Disorders of Hemostasis

Hemostasis, the process that stops bleeding after a blood vessel injury, is crucial for maintaining the integrity of the circulatory system. However, disorders of hemostasis can disrupt this delicate balance, leading to either excessive clotting or bleeding. These disorders can be broadly classified into thromboembolic disorders and bleeding disorders.
Thromboembolic Disorders
Two factors primarily cause thromboembolic conditions.
2.6K
Anticoagulant Drugs: Vitamin K Antagonists and Direct Oral Anticoagulants01:18

Anticoagulant Drugs: Vitamin K Antagonists and Direct Oral Anticoagulants

Oral anticoagulants are vital tools in preventing and treating blood clotting disorders. This diverse class of medications can be categorized as vitamin K antagonists, exemplified by warfarin, and direct thrombin inhibitors (DTIs), such as dabigatran, as well as factor Xa inhibitors, including rivaroxaban.
Warfarin, a prominent vitamin K antagonist family member, exerts its effect by inhibiting the enzyme VKORC1 (vitamin K epoxide reductase complex 1). By hindering this enzyme, warfarin...
2.6K